Review of: Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. Erratum in: BMJ. 2017;358:j4461.Includes bibliographical references2 pagesAntidepressant Tx for anxiety disorders: How long? This systematic review/meta-analysis provides some long-awaited evidence regarding the length of time to treat to minimize the risk of relapse. PRACTICE CHANGER: Keep patients on antidepressant therapy for anxiety disorders for a year or longer before considering a taper.Patricia McGuire, MD; Gregory Castelli, PharmD, BCPS, BC-ADM, UPMC St. Margaret, Pittsburgh, P
